table of content
1 Introduction to Research & Analysis Reports
1.1 Colorectal Cancer Diagnostics & Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Colorectal Cancer Diagnostics & Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Colorectal Cancer Diagnostics & Therapeutics Overall Market Size
2.1 Global Colorectal Cancer Diagnostics & Therapeutics Market Size: 2022 VS 2030
2.2 Global Colorectal Cancer Diagnostics & Therapeutics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Colorectal Cancer Diagnostics & Therapeutics Players in Global Market
3.2 Top Global Colorectal Cancer Diagnostics & Therapeutics Companies Ranked by Revenue
3.3 Global Colorectal Cancer Diagnostics & Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Colorectal Cancer Diagnostics & Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Colorectal Cancer Diagnostics & Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Colorectal Cancer Diagnostics & Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Colorectal Cancer Diagnostics & Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Colorectal Cancer Diagnostics & Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Colorectal Cancer Diagnostics & Therapeutics Market Size Markets, 2022 & 2030
4.1.2 Colorectal Cancer Diagnostics
4.1.3 Colorectal Cancer Therapeutics
4.2 By Type - Global Colorectal Cancer Diagnostics & Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Colorectal Cancer Diagnostics & Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Colorectal Cancer Diagnostics & Therapeutics Revenue, 2024-2030
4.2.3 By Type - Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Colorectal Cancer Diagnostics & Therapeutics Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Specialty Clinics
5.1.4 Others
5.2 By Application - Global Colorectal Cancer Diagnostics & Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Colorectal Cancer Diagnostics & Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Colorectal Cancer Diagnostics & Therapeutics Revenue, 2024-2030
5.2.3 By Application - Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Colorectal Cancer Diagnostics & Therapeutics Market Size, 2022 & 2030
6.2 By Region - Global Colorectal Cancer Diagnostics & Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Colorectal Cancer Diagnostics & Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Colorectal Cancer Diagnostics & Therapeutics Revenue, 2024-2030
6.2.3 By Region - Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Colorectal Cancer Diagnostics & Therapeutics Revenue, 2018-2030
6.3.2 US Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.3.3 Canada Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.3.4 Mexico Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Colorectal Cancer Diagnostics & Therapeutics Revenue, 2018-2030
6.4.2 Germany Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.4.3 France Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.4.4 U.K. Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.4.5 Italy Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.4.6 Russia Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.4.7 Nordic Countries Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.4.8 Benelux Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Colorectal Cancer Diagnostics & Therapeutics Revenue, 2018-2030
6.5.2 China Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.5.3 Japan Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.5.4 South Korea Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.5.5 Southeast Asia Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.5.6 India Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Colorectal Cancer Diagnostics & Therapeutics Revenue, 2018-2030
6.6.2 Brazil Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.6.3 Argentina Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Revenue, 2018-2030
6.7.2 Turkey Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.7.3 Israel Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.7.4 Saudi Arabia Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
6.7.5 UAE Colorectal Cancer Diagnostics & Therapeutics Market Size, 2018-2030
7 Colorectal Cancer Diagnostics & Therapeutics Companies Profiles
7.1 Biocept
7.1.1 Biocept Company Summary
7.1.2 Biocept Business Overview
7.1.3 Biocept Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.1.4 Biocept Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Biocept Key News & Latest Developments
7.2 Cancer Genetics
7.2.1 Cancer Genetics Company Summary
7.2.2 Cancer Genetics Business Overview
7.2.3 Cancer Genetics Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.2.4 Cancer Genetics Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Cancer Genetics Key News & Latest Developments
7.3 Foundation Medicine
7.3.1 Foundation Medicine Company Summary
7.3.2 Foundation Medicine Business Overview
7.3.3 Foundation Medicine Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.3.4 Foundation Medicine Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Foundation Medicine Key News & Latest Developments
7.4 Sysmex Corporation
7.4.1 Sysmex Corporation Company Summary
7.4.2 Sysmex Corporation Business Overview
7.4.3 Sysmex Corporation Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.4.4 Sysmex Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Sysmex Corporation Key News & Latest Developments
7.5 Danaher Corporation
7.5.1 Danaher Corporation Company Summary
7.5.2 Danaher Corporation Business Overview
7.5.3 Danaher Corporation Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.5.4 Danaher Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Danaher Corporation Key News & Latest Developments
7.6 Epigenomics
7.6.1 Epigenomics Company Summary
7.6.2 Epigenomics Business Overview
7.6.3 Epigenomics Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.6.4 Epigenomics Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Epigenomics Key News & Latest Developments
7.7 Illumina
7.7.1 Illumina Company Summary
7.7.2 Illumina Business Overview
7.7.3 Illumina Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.7.4 Illumina Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Illumina Key News & Latest Developments
7.8 Rosetta Genomics
7.8.1 Rosetta Genomics Company Summary
7.8.2 Rosetta Genomics Business Overview
7.8.3 Rosetta Genomics Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.8.4 Rosetta Genomics Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Rosetta Genomics Key News & Latest Developments
7.9 Exact Science Corporation
7.9.1 Exact Science Corporation Company Summary
7.9.2 Exact Science Corporation Business Overview
7.9.3 Exact Science Corporation Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.9.4 Exact Science Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.9.5 Exact Science Corporation Key News & Latest Developments
7.10 Pathway Genomics Corporation
7.10.1 Pathway Genomics Corporation Company Summary
7.10.2 Pathway Genomics Corporation Business Overview
7.10.3 Pathway Genomics Corporation Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.10.4 Pathway Genomics Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.10.5 Pathway Genomics Corporation Key News & Latest Developments
7.11 Taiho Pharma
7.11.1 Taiho Pharma Company Summary
7.11.2 Taiho Pharma Business Overview
7.11.3 Taiho Pharma Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.11.4 Taiho Pharma Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.11.5 Taiho Pharma Key News & Latest Developments
7.12 Merck KGaA
7.12.1 Merck KGaA Company Summary
7.12.2 Merck KGaA Business Overview
7.12.3 Merck KGaA Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.12.4 Merck KGaA Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.12.5 Merck KGaA Key News & Latest Developments
7.13 Amgen
7.13.1 Amgen Company Summary
7.13.2 Amgen Business Overview
7.13.3 Amgen Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.13.4 Amgen Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.13.5 Amgen Key News & Latest Developments
7.14 Takeda
7.14.1 Takeda Company Summary
7.14.2 Takeda Business Overview
7.14.3 Takeda Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.14.4 Takeda Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.14.5 Takeda Key News & Latest Developments
7.15 Roche
7.15.1 Roche Company Summary
7.15.2 Roche Business Overview
7.15.3 Roche Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.15.4 Roche Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.15.5 Roche Key News & Latest Developments
7.16 Eli Lilly
7.16.1 Eli Lilly Company Summary
7.16.2 Eli Lilly Business Overview
7.16.3 Eli Lilly Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.16.4 Eli Lilly Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.16.5 Eli Lilly Key News & Latest Developments
7.17 Sanofi
7.17.1 Sanofi Company Summary
7.17.2 Sanofi Business Overview
7.17.3 Sanofi Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.17.4 Sanofi Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.17.5 Sanofi Key News & Latest Developments
7.18 Regeneron
7.18.1 Regeneron Company Summary
7.18.2 Regeneron Business Overview
7.18.3 Regeneron Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.18.4 Regeneron Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.18.5 Regeneron Key News & Latest Developments
7.19 Bayer
7.19.1 Bayer Company Summary
7.19.2 Bayer Business Overview
7.19.3 Bayer Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.19.4 Bayer Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.19.5 Bayer Key News & Latest Developments
7.20 Onyx
7.20.1 Onyx Company Summary
7.20.2 Onyx Business Overview
7.20.3 Onyx Colorectal Cancer Diagnostics & Therapeutics Major Product Offerings
7.20.4 Onyx Colorectal Cancer Diagnostics & Therapeutics Revenue in Global Market (2018-2023)
7.20.5 Onyx Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
